Discovery Stage IND EXEMPT Clinical Study - Etoposide and Single Nucleotide Polymorphisms (Drugs-SNPs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01064466
Recruitment Status : Active, not recruiting
First Posted : February 8, 2010
Last Update Posted : November 22, 2017
Information provided by (Responsible Party):
Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair, Medicine Invention Design, Inc